Raymond James & Associates’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $49.6K | Sell |
|
|||||
|
2024
Q2 | $39.2K | Hold |
|
|||||
|
2024
Q1 | $55.4K | Sell |
|
|||||
|
2023
Q4 | $216K | Sell |
|
|||||
|
2023
Q3 | $185K | Buy |
|
|||||
|
2023
Q2 | $181K | Sell |
|
|||||
|
2023
Q1 | $245K | Sell |
|
|||||
|
2022
Q4 | $243K | Sell |
|
|||||
|
2022
Q3 | $299K | Sell |
|
|||||
|
2022
Q2 | $200K | Sell |
|
|||||
|
2022
Q1 | $180K | Buy |
|
|||||
|
2021
Q4 | $169K | Buy |
|
|||||
|
2021
Q3 | $246K | Sell |
|
|||||
|
2021
Q2 | $210K | Buy |
|
|||||
|
2021
Q1 | $198K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $16K | Hold |
|
|||||
|
2019
Q4 | $33K | Hold |
|
|||||
|
2019
Q3 | $40K | Hold |
|
|||||
|
2019
Q2 | $36K | Buy |
|